ThetaPal ThetaPal

Manufacturing / Biological Products, Except Diagnostic Substances

Taysha Gene Therapies, Inc.

TSHA

$6.23

+$0.24 (+4.02%)

Price as of Aug 25, 2026 16:21 UTC

1.9 B

Market Cap (Small Cap)

21%

IV Rank

108.2%

Implied Volatility

Nov 02

Next Earnings

Price & Trend

Daily candles with EMA 20, SMA 50. Drag to zoom.

Options Activity & Greeks

Implied volatility, flow, and dealer positioning from the options market.

Put/Call Ratio

11.51

Bearish skew

Implied Volatility

108.2%

0% percentile

IV vs Realized

Options rich

30d HV 65.7%

Options Heat Map

Delta-risk grid for TSHA options across strikes and expirations. Hover any cell for full Greeks.

Loading option chain data...

Insider Trades

1 buys 15 sells
Date Insider Title Type Shares Value
Jul 10, 2026 Nagendran Sukumar Sell 200,000 $1,248,000
Jun 01, 2026 Long Alison S Grant 42,671 $0
Jun 01, 2026 Long Alison S Grant 21,335 $0
Jun 01, 2026 Sepp-Lorenzino Laura Grant 42,671 $0
Jun 01, 2026 Sepp-Lorenzino Laura Grant 21,335 $0
Jun 01, 2026 Stalfort John A III Grant 42,671 $0
Jun 01, 2026 Stalfort John A III Grant 21,335 $0
Jun 01, 2026 Donenberg Phillip B. Grant 42,671 $0
Jun 01, 2026 Donenberg Phillip B. Grant 21,335 $0
Jun 01, 2026 Long Alison S Other 42,671 $0

Earnings History

Date Quarter EPS Est. EPS Actual Surprise Result
Aug 17, 2026 Q2 2026 -$0.12
Aug 11, 2026 Q2 2026 -$0.12
Aug 10, 2026 Q2 2026 -$0.12
Jun 30, 2026 Q2 2026 -$0.12 -$0.13 -9.3% Miss
Mar 31, 2026 Q1 2026 -$0.10 -$0.12 -20.5% Miss
Dec 31, 2025 Q4 2025 -$0.10 -$0.08 +18.5% Beat
Sep 30, 2025 Q3 2025 -$0.09 -$0.09 +0.0% Beat
Jun 30, 2025 Q2 2025 -$0.08 -$0.09 -9.1% Miss

Track TSHA with ThetaPal

Get insider trade alerts, AI portfolio analysis, and options roll recommendations for TSHA and your entire portfolio.